FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 351:2827-2831 December 30, 2004 Number 27 Next

	Full Text PDF PDA Full Text PowerPoint Slide Set Editorial by Caraco, Y. Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear Related Article PubMed Citation

SUMMARY

Life-threatening opioid intoxication developed in a patient after he was given small doses of codeine for the treatment of a cough associated with bilateral pneumonia. Codeine is bioactivated by CYP2D6 into morphine, which then undergoes further glucuronidation. CYP2D6 genotyping showed that the patient had three or more functional alleles, a finding consistent with ultrarapid metabolism of codeine. We attribute the toxicity to this genotype, in combination with inhibition of CYP3A4 activity by other medications and a transient reduction in renal function.

Source Information

From the Divisions of Surgical (Y.G., S.C.) and Medical Intensive Care (Y.G.), Clinical Pharmacology and Toxicology (Y.D., P.D., J.D.), and Clinical Chemistry (M.F., A.C.), Geneva University Hospital, Geneva.

Address reprint requests to Dr. Gasche at the Division of Surgical Intensive Care, Department of Anesthesiology, Pharmacology, and Surgical Intensive Care, Geneva University Hospital, 24 rue Micheli-du-Crest, CH-1211 Geneva, Switzerland, or at yvan.gasche{at}medecine.unige.ch.

Full Text of this Article

This article has been cited by other articles:

• Brauch, H., Murdter, T. E., Eichelbaum, M., Schwab, M. (2009). Pharmacogenomics of Tamoxifen Therapy. Clin. Chem. 55: 1770-1782 [Abstract] [Full Text]  
• Hogan, K. J., Burmester, J. K., Caldwell, M. D., Hogan, Q. H., Coursin, D. B., Green, D. N., Selzer, R. M.R., Broderick, T. P., Rusy, D. A., Poroli, M., Lutz, A. L., Sanders, A. M., Oldenburg, M. C., Koelbl, J. A., de Arruda-Indig, M., Halsey, J. L., Day, S. P., Domanico, M. J. (2009). Perioperative Genomic Profiles Using Structure-Specific Oligonucleotide Probes. Clin Med Res 7: 69-84 [Abstract] [Full Text]  
• Hosono, N., Kato, M., Kiyotani, K., Mushiroda, T., Takata, S., Sato, H., Amitani, H., Tsuchiya, Y., Yamazaki, K., Tsunoda, T., Zembutsu, H., Nakamura, Y., Kubo, M. (2009). CYP2D6 Genotyping for Functional-Gene Dosage Analysis by Allele Copy Number Detection. Clin. Chem. 55: 1546-1554 [Abstract] [Full Text]  
• Smith, H. S. (2009). Opioid Metabolism. Mayo Clin Proc. 84: 613-624 [Abstract] [Full Text]  
• Sakuyama, K., Sasaki, T., Ujiie, S., Obata, K., Mizugaki, M., Ishikawa, M., Hiratsuka, M. (2008). Functional Characterization of 17 CYP2D6 Allelic Variants (CYP2D6.2, 10, 14A-B, 18, 27, 36, 39, 47-51, 53-55, and 57). Drug Metab. Dispos. 36: 2460-2467 [Abstract] [Full Text]  
• Stamer, U. M., Stuber, F., Muders, T., Musshoff, F. (2008). Respiratory Depression with Tramadol in a Patient with Renal Impairment and CYP2D6 Gene Duplication. Anesth. Analg. 107: 926-929 [Abstract] [Full Text]  
• Pattinson, K. T. S. (2008). Opioids and the control of respiration. Br J Anaesth 100: 747-758 [Abstract] [Full Text]  
• Lee, H.-K., Lewis, L. D., Tsongalis, G. J., Schur, B. C., Jannetto, P. J., Wong, S. H., Yeo, K.-T. J. (2007). Validation of a CYP2D6 Genotyping Panel on the NanoChip Molecular Biology Workstation. Clin. Chem. 53: 823-828 [Abstract] [Full Text]  
• Kim, Y. M., Yoo, S. H., Kang, R. Y., Kim, M. J., Bae, Y. Y., Lee, Y. K., Jeon, S. J., Chon, K. J., Shin, S. M., Kim, S. G., Park, K. H., Son, I. J. (2007). Identifying drugs needing pharmacogenetic monitoring in a Korean hospital. Am J Health Syst Pharm 64: 166-175 [Abstract] [Full Text]  
• Madadi, P., Koren, G., Cairns, J., Chitayat, D., Gaedigk, A., Leeder, J. S., Teitelbaum, R., Karaskov, T., Aleksa, K. (2007). Safety of codeine during breastfeeding: Fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. cfp 53: 33-35 [Abstract] [Full Text]  
• Gardiner, S. J., Begg, E. J. (2006). Pharmacogenetics, Drug-Metabolizing Enzymes, and Clinical Practice. Pharmacol. Rev. 58: 521-590 [Abstract] [Full Text]  
• Garrison, L. P. Jr., Austin, M.J. F. (2006). Linking Pharmacogenetics-Based Diagnostics And Drugs For Personalized Medicine. Health Aff (Millwood) 25: 1281-1290 [Abstract] [Full Text]  
• Janicki, P. K., Schuler, H. G., Jarzembowski, T. M., Rossi, M. II (2006). Prevention of Postoperative Nausea and Vomiting with Granisetron and Dolasetron in Relation to CYP2D6 Genotype.. Anesth. Analg. 102: 1127-1133 [Abstract] [Full Text]  
• Zhu, W., Cadet, P., Baggerman, G., Mantione, K. J., Stefano, G. B. (2005). Human White Blood Cells Synthesize Morphine: CYP2D6 Modulation. J. Immunol. 175: 7357-7362 [Abstract] [Full Text]  
• Ingelman-Sundberg, M., Rodriguez-Antona, C. (2005). Pharmacogenetics of drug-metabolizing enzymes: implications for a safer and more effective drug therapy. Phil Trans R Soc B 360: 1563-1570 [Abstract] [Full Text]  
• Wilkinson, G. R. (2005). Drug Metabolism and Variability among Patients in Drug Response. NEJM 352: 2211-2221 [Full Text]  
• Caraco, Y. (2004). Genes and the Response to Drugs. NEJM 351: 2867-2869 [Full Text]